Eymard, N.
Bessonov, N.
Volpert, V.
Kurbatova, P.
Gueyffier, F.
Nony, P.
Article History
Received: 28 December 2020
Accepted: 17 January 2023
First Online: 7 March 2023
Declarations
:
: This work was funded by Erytech pharma. N. Eymard and P. Kurbatova were employed by EZUS, private subsidiary of Lyon 1 university. F. Gueyffier and P. Nony declared no conflict of interest. N. Bessonov and V. Volpert are external consultants